Cerus Corp. (CERS)
2.65
-0.07
(-2.57%)
USD |
NASDAQ |
Aug 28, 16:00
2.655
0.00 (0.00%)
After-Hours: 20:00
Cerus Price to Book Value : 7.624 for Aug. 28, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 7.624 |
| August 27, 2026 | 7.825 |
| August 26, 2026 | 7.883 |
| August 25, 2026 | 7.825 |
| August 24, 2026 | 7.739 |
| August 21, 2026 | 8.084 |
| August 20, 2026 | 8.027 |
| August 19, 2026 | 8.199 |
| August 18, 2026 | 7.940 |
| August 17, 2026 | 8.545 |
| August 14, 2026 | 8.573 |
| August 13, 2026 | 8.171 |
| August 12, 2026 | 7.796 |
| August 11, 2026 | 7.379 |
| August 10, 2026 | 7.250 |
| August 07, 2026 | 6.761 |
| August 06, 2026 | 6.674 |
| August 05, 2026 | 6.531 |
| August 04, 2026 | 6.300 |
| August 03, 2026 | 6.186 |
| July 31, 2026 | 6.186 |
| July 30, 2026 | 8.314 |
| July 29, 2026 | 8.257 |
| July 28, 2026 | 8.401 |
| July 27, 2026 | 8.832 |
| Date | Value |
|---|---|
| July 24, 2026 | 8.430 |
| July 23, 2026 | 8.257 |
| July 22, 2026 | 8.688 |
| July 21, 2026 | 8.976 |
| July 20, 2026 | 9.062 |
| July 17, 2026 | 9.005 |
| July 16, 2026 | 9.235 |
| July 15, 2026 | 9.149 |
| July 14, 2026 | 8.832 |
| July 13, 2026 | 8.890 |
| July 10, 2026 | 8.976 |
| July 09, 2026 | 9.062 |
| July 08, 2026 | 9.034 |
| July 07, 2026 | 9.264 |
| July 06, 2026 | 9.436 |
| July 02, 2026 | 9.091 |
| July 01, 2026 | 8.631 |
| June 30, 2026 | 8.401 |
| June 29, 2026 | 8.866 |
| June 26, 2026 | 8.659 |
| June 25, 2026 | 8.481 |
| June 24, 2026 | 7.828 |
| June 23, 2026 | 7.680 |
| June 22, 2026 | 7.710 |
| June 18, 2026 | 8.006 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| DexCom, Inc. | 13.08 |
| Abbott Laboratories | 3.808 |
| AngioDynamics, Inc. | 3.869 |
| Alphatec Holdings, Inc. | -- |
| AtriCure, Inc. | 4.781 |
Price to Book Value Related Metrics
| PS Ratio | 2.328 |
| Price | 2.65 |
| Earnings Yield | -1.31% |
| Market Cap | 533.86M |